Pharmaceutical Companies

The latest meeting of the Committee for Medicinal Products for Human Use (CHMP) has ushered in notable advancements in the pharmaceutical landscape with ten...

In a compelling breakthrough for Type 1 diabetes (T1D) treatment, Teizeild, a pharmaceutical innovation from Sanofi Winthrop Industrie, recently received a pivotal endorsement from...

The European Union’s nod to cilofexor marks a significant moment in the medical field, specifically for treating primary sclerosing cholangitis (PSC). As cometitor drugs...

In a world where vision becomes compromised with age, Apellis Pharmaceuticals introduces a beacon of hope through its comprehensive data from the GALE extension...

In the heart of Tarrytown, New York, a wave of excitement emanates from Regeneron Pharmaceuticals as the company prepares to unveil significant advancements at...

Merck takes a strategic leap forward with its recent acquisition of Cidara Therapeutics, a move reflecting both companies' commitment to advancing influenza prevention. By...

Takeda has released promising interim data from its Phase 1b clinical study, showcasing the sustained efficacy of mezagitamab in primary IgA nephropathy treatment. This...

At the American Heart Association's 2025 Scientific Sessions, revolutionary findings emerged about olezarsen's potential in treating severe hypertriglyceridemia (sHTG). These groundbreaking results, presented as...

Collegium Pharmaceutical is riding a wave of robust growth, closing the third quarter of 2025 with exceptional financial results. The company revealed a striking...

A recent breakthrough by Camurus has revealed positive data from their Phase 1b study on CAM2056, a monthly semaglutide formulation. Unveiling a significant stride...

Regeneron Pharmaceuticals, Inc. and Sanofi have announced impressive outcomes from their recent Phase 3 trial, showcasing the effectiveness of Dupixent in alleviating allergic fungal...

Takeda Pharmaceutical Company has set a new benchmark in dengue prevention with its QDENGA® dengue vaccine, which has demonstrated an impressive 7-year protective efficacy...

Sumitomo Pharma America, Inc. (SMPA) presents its latest research breakthroughs in the realms of acute myeloid leukemia (AML) and myelofibrosis (MF) at the 67th...

Dupixent® (dupilumab), a therapeutic innovation by Regeneron Pharmaceuticals, has been lauded for its unparalleled contributions to treating allergic and atopic conditions. Acknowledged by the...

Today marks a significant milestone in the treatment of systemic lupus erythematosus (SLE). Roche has unveiled results from their highly anticipated phase III ALLEGORY...